The worldwide trauma market has experienced significant growth in the past and the market has considerable growth opportunity in the near future as the worldwide demand for trauma products is increasing gradually.
The US was the largest market for trauma products in 2010. The trauma market in the US has grown significantly during 2009-2010, majorly due to growing aging population and road accidents in the country. However, the growth of the market was partially offset by lower average selling prices of trauma products.
The internal fixation market segment, specifically the market for plates and screws experienced elevated sales in 2010, compared to the other market segments in the US trauma market.
Consolidation among major players, increased usage of external fixation products, growing usage of instrumentation, and cost optimization by major players were the key trends of global trauma market, whereas, the major market drivers were growing aging population and increasing number of vehicles.
The global trauma market is controlled by a limited number of players and Synthes is the market leader followed by Stryker, Smith & Nephew, Zimmer, and J&J Depuy. Synthes is also the market leader in the US trauma market.
The present report offers an analysis of the worldwide trauma market. It provides a competitive landscape of the market along with the major growth drivers. The report also profiles the major companies operating in the trauma market, with a discussion of their key business strategies.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the global trauma market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Genetic testing, which is also known as DNA testing, is the latest innovation in the field of molecular diagnostics. The genetic testing market segment represents the highest growth opportunity compared to other segments within the molecular diagnostics market. The growth of the market is b ... mehr
The biosimilar market is presently a small segment of the pharmaceutical industry. However, in the years to come, the market for biosimilars has huge growth opportunity despite of the high entry barriers. The governments in the developed countries are desperately trying to control their nat ... mehr
Human being has evolved with an unending quest for exploration. With constant research in medical and other sciences, molecular diagnostic tools and techniques were developed. Besides providing the medical work and a wider spectrum and accuracy of test findings, these tests have also enable ... mehr